A new clinical classification system is presented to define the severity of an acute PE and assist in developing adult treatment strategies.

Stories this month focused on TAVI in low-risk patients, statin safety, the burden of CKM syndrome in the US, and more.

To report SUSPECTED ADVERSE REACTIONS, contact Sun Pharmaceutical Industries, Inc. at 1- 800-818-4555 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. INDICATION WINLEVI (clascoterone) cream 1% is an ...

Full-day postgraduate and advanced trainee workshops scheduled for 27 March 2026 at Perth Convention Centre, focusing on strengthening ...

Researchers tested ChatGPT's health feature with textbook medical emergencies and found it failed to recommend urgent care in nearly 30% of critical cases — and the people most likely to be harmed are ...

Patients with pulmonary adenocarcinoma consulted the neurology department due to multiple initial symptoms of cerebral ischaemia. Examination of each patient revealed pulmonary embolism, the ...

The Society of Interventional Radiology (SIR) published new practice guidance for the treatment of chronic pelvic pain in ...

The 32nd Actor Awards ceremony at the Shrine Auditorium was always going to be an emotional night, but Sunday turned into a ...

AFTX-201 uses a proprietary capsid to deliver a human BAG3 transgene, aiming to restore cardiac function with lower doses than conventional gene therapies.

Across hospitals and health systems, stroke care sits at the intersection of several pressures leaders know well: rising acuity, uneven access to specialty care, workforce constraints and growing ...

Dr. Frank Brodkey shares key insights from andexanet's development, approval, and real-world clinical trajectory.

Groundbreaking Phase 1/2a clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago ...